Fig. 2From: Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinomaDistribution of SUVmax of DTC tumors stratified by tumor size and BRAFV600E mutation status. * significant difference. ns: not significantBack to article page